GLG LLC’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$2.1M Hold
17,895
0.15% 168
2017
Q3
$2.03M Buy
17,895
+8,635
+93% +$997K 0.13% 205
2017
Q2
$1.15M Sell
9,260
-1,076
-10% -$128K 0.07% 292
2017
Q1
$1.23M Sell
10,336
-24
-0.2% -$2.72K 0.07% 301
2016
Q4
$1.04M Buy
10,360
+658
+7% +$70.5K 0.07% 271
2016
Q3
$1.23M Sell
9,702
-901
-8% -$111K 0.09% 250
2016
Q2
$1.24M Sell
10,603
-2,039
-16% -$231K 0.09% 228
2016
Q1
$1.31M Sell
12,642
-1,955
-13% -$189K 0.08% 256
2015
Q4
$1.45M Sell
14,597
-9,872
-40% -$966K 0.09% 239
2015
Q3
$2.23M Sell
24,469
-77
-0.3% -$7.72K 0.06% 288
2015
Q2
$2.6M Sell
24,546
-8,270
-25% -$915K 0.06% 314
2015
Q1
$3.74M Buy
32,816
+3,237
+11% +$369K 0.11% 217
2014
Q4
$3.26M Hold
29,579
0.1% 229
2014
Q3
$2.89M Hold
29,579
0.08% 302
2014
Q2
$2.98M Sell
29,579
-20,600
-41% -$2.01M 0.09% 293
2014
Q1
$4.61M Buy
+50,179
New +$4.62M 0.15% 184

Other funds holding ZBH

GLG LLC's ZBH Position: Q4 2017 in Review

GLG LLC held its Zimmer Biomet (ZBH) position steady in Q4 2017 at 17,895 shares worth $2.1M. The position accounts for 0.15% of the portfolio, ranked #168.

GLG LLC first reported a position in ZBH in Q1 2014 and has held it in 16 quarters since. The position peaked at $4.61M in Q1 2014. 870 funds tracked by Wall St. Rank hold ZBH as of Q4 2017.

  • GLG LLC held 17,895 shares of Zimmer Biomet worth $2.1M as of Q4 2017.
  • GLG LLC left its Zimmer Biomet share count unchanged in Q4 2017.
  • Zimmer Biomet made up 0.15% of GLG LLC's portfolio in Q4 2017, its #168 holding.
  • GLG LLC first reported a position in Zimmer Biomet in Q1 2014 and has held it in 16 quarters since.
  • GLG LLC's Zimmer Biomet position peaked at $4.61M in Q1 2014.
  • 870 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.